Biotech Products Services and Research, Inc. announced the launch of its wholly-owned subsidiary, General Surgical Florida, Inc. The team at General Surgical will work towards establishing sales distribution channels of regenerative products to hospitals, physicians and third party distributors. Specifically, General Surgical will be providing access to advanced regenerative medical technologies.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.5 USD | +4.17% |
|
+31.98% | +154.90% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+154.90% | 15.2M | |
+25.52% | 75.01B | |
-5.69% | 22.83B | |
+15.24% | 8.76B | |
-6.01% | 7.84B | |
-33.02% | 6.68B | |
+20.94% | 5.59B | |
+4.33% | 4.21B | |
-3.66% | 4.05B | |
+12.62% | 3.41B |
- Stock Market
- Equities
- ZEOX Stock
- News Zeo ScientifiX, Inc.
- Biotech Products Services & Research, Inc. Launches General Surgical Subsidiary 'General Surgical Florida, Inc.'